UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060006
Receipt number R000068630
Scientific Title Study on the Effects of Lung Resection on Patients' Sleep
Date of disclosure of the study information 2025/12/08
Last modified on 2025/12/07 22:07:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the Effects of Lung Resection on Patients' Sleep

Acronym

LSAStudy

Scientific Title

Study on the Effects of Lung Resection on Patients' Sleep

Scientific Title:Acronym

LSAStudy

Region

Japan


Condition

Condition

Lung tumor

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To prospectively evaluate the effects of lung resection surgery for pulmonary tumors on patients' sleep status, focusing on the incidence and severity of sleep apnea syndrome (SAS) and examining differences according to surgical procedures

Basic objectives2

Others

Basic objectives -Others

As secondary objectives, this study will explore the associations between postoperative sleep disturbances and clinical parameters, including arterial blood gas findings, pulmonary function tests, subjective sleepiness (Epworth Sleepiness Scale), quality of life (SF-36), and prognostic outcomes (recurrence, rehospitalization, mortality).

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. Apnea-hypopnea index (AHI).
2. Oxygen Desaturation Index (ODI).
3. Sleep efficiency
These outcomes will be assessed using simplified polysomnography (PSG) at baseline (preoperatively) and 1 year postoperatively.
For patients without a preoperative PSG evaluation, exploratory assessments will be conducted at one, two, three and five years postoperatively, provided that informed consent is obtained at these time points.

Key secondary outcomes

Arterial blood gas findings at baseline and, exploratorily, at 1 year postoperatively (only in patients with available data)
Pulmonary function tests (%VC, FEV1, etc.)
Epworth Sleepiness Scale for subjective sleepiness assessment
Duration of apnea episodes measured by simplified PSG
Quality of life assessment (e.g., SF-36, if available)
Prognostic information (recurrence, rehospitalization, mortality)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Adult patients scheduled to undergo thoracic surgery for pulmonary tumors, with written informed consent

Key exclusion criteria

Patients already diagnosed with sleep apnea syndrome (SAS) preoperatively, or those judged unable to complete follow-up

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Gaku
Middle name
Last name Yamaguchi

Organization

International University of Health and Welfare, Ichikawa Hospital

Division name

Thoracic Surgery

Zip code

272-0827

Address

6-1-14 Kounodai, Ichikawa-shi, Chiba, Japan

TEL

0473751111

Email

ugaku@hotmail.com


Public contact

Name of contact person

1st name Gaku
Middle name
Last name Yamaguchi

Organization

International University of Health and Welfare, Ichikawa Hospital

Division name

Division of Thoracic Surgery

Zip code

2720827

Address

6-1-14 Kounodai, Ichikawa-shi, Chiba, Japan

TEL

0472751111

Homepage URL


Email

ugaku@hotmail.com


Sponsor or person

Institute

Internatinonal University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

No external funding (self-funded study)

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba District Ethics Review Committee International University of Health and Welfare, Ichikawa Hospital

Address

6-1-14 Kounodai, Ichikawa-shi, Chiba, Japan

Tel

0473751111

Email

ugaku@hotmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 11 Month 25 Day

Date of IRB


Anticipated trial start date

2025 Year 12 Month 08 Day

Last follow-up date

2029 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is a single-center, prospective observational study conducted at the International University of Health and Welfare, Ichikawa Hospital. Adult patients undergoing thoracic surgery for pulmonary tumors will be evaluated using simplified polysomnography (PSG) before surgery and at 1 year postoperatively. For patients without preoperative PSG, exploratory assessments may be performed at 1-5 years postoperatively. Primary outcomes include AHI, ODI, and sleep efficiency, while secondary outcomes include arterial blood gas findings, pulmonary function tests, subjective sleepiness, quality of life, and prognostic information.


Management information

Registered date

2025 Year 12 Month 07 Day

Last modified on

2025 Year 12 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068630